| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A4 SLC9A4 SLC35A3 SLC26A3 CLCN5 SLC16A9 SLCO2A1 SLC26A4 SLC35A2 SLC35C2 SLC34A2 SLC45A2 SLC44A4 SLC1A2 SLC26A6 SLC45A4 | 3.38e-14 | 296 | 79 | 16 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A4 SLC9A4 SLC35A3 SLC26A3 CLCN5 SLC16A9 SLCO2A1 SLC26A4 CFTR SLC35A2 SLC35C2 SLC34A2 SLC45A2 SLC44A4 SLC1A2 SLC26A6 SLC45A4 | 4.14e-12 | 477 | 79 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 CHRNA6 SLC9A4 SLC35A3 SLC26A3 ATP8B4 TMC2 CLCN5 SLC16A9 SLCO2A1 SLC26A4 CFTR SLC35A2 SLC35C2 PEX2 SLC34A2 SLC45A2 SERINC5 OTOP3 SLC44A4 SLC1A2 SLC26A6 RYR3 SLC45A4 | 8.09e-11 | 1289 | 79 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 CHRNA6 SLC9A4 SLC35A3 SLC26A3 TMC2 CLCN5 SLC16A9 SLCO2A1 SLC26A4 CFTR SLC35A2 SLC35C2 PEX2 SLC34A2 SLC45A2 SERINC5 OTOP3 SLC44A4 SLC1A2 SLC26A6 RYR3 SLC45A4 | 9.04e-11 | 1180 | 79 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | antiporter activity | SLC6A4 SLC9A4 SLC35A3 SLC26A3 CLCN5 SLC26A4 SLC35A2 SLC35C2 SLC44A4 SLC26A6 | 1.72e-10 | 138 | 79 | 10 | GO:0015297 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC35A3 SLC26A3 SLC16A9 SLCO2A1 SLC26A4 CFTR SERINC5 SLC44A4 SLC1A2 SLC26A6 | 2.34e-07 | 293 | 79 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A4 CHRNA6 SLC9A4 SLC26A3 TMC2 CLCN5 SLC26A4 CFTR SLC34A2 SLC45A2 OTOP3 SLC1A2 SLC26A6 RYR3 SLC45A4 | 4.26e-07 | 793 | 79 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A4 SLC9A4 SLC26A3 TMC2 CLCN5 SLC26A4 CFTR SLC34A2 SLC45A2 OTOP3 SLC1A2 SLC26A6 RYR3 SLC45A4 | 1.44e-06 | 758 | 79 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.26e-06 | 151 | 79 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC6A4 SLC9A4 SLC26A3 SLC26A4 SLC34A2 SLC45A2 SLC1A2 SLC26A6 SLC45A4 | 2.91e-06 | 301 | 79 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.27e-06 | 61 | 79 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.16e-06 | 171 | 79 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 7.01e-06 | 10 | 79 | 3 | GO:0019531 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.50e-06 | 32 | 79 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 9.61e-06 | 11 | 79 | 3 | GO:0008271 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.02e-05 | 125 | 79 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.66e-05 | 13 | 79 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.66e-05 | 13 | 79 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | symporter activity | 2.88e-05 | 150 | 79 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 3.22e-05 | 16 | 79 | 3 | GO:0015116 | |
| GeneOntologyMolecularFunction | UDP-galactose transmembrane transporter activity | 4.62e-05 | 3 | 79 | 2 | GO:0005459 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CHRNA6 LYVE1 CD4 OR4N2 GPR20 PTPRH OR4N4 HLA-DQB1 HLA-DQB2 PTCH2 MRGPRX2 GPRC5C GPRC5D GPRC5A LTB4R2 LILRA4 | 6.66e-05 | 1353 | 79 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | sucrose transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0008515 | |
| GeneOntologyMolecularFunction | sucrose:proton symporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0008506 | |
| GeneOntologyMolecularFunction | oligosaccharide transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0015157 | |
| GeneOntologyMolecularFunction | disaccharide transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0015154 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 9.23e-05 | 4 | 79 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | sucrose:monoatomic cation symporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0009669 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.10e-04 | 119 | 79 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 1.63e-04 | 27 | 79 | 3 | GO:0023026 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.71e-04 | 207 | 79 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.76e-04 | 208 | 79 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 2.47e-04 | 31 | 79 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.72e-04 | 32 | 79 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A4 CHRNA6 SLC9A4 TMC2 SLC34A2 SLC45A2 OTOP3 SLC1A2 RYR3 SLC45A4 | 2.82e-04 | 664 | 79 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.29e-04 | 83 | 79 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 4.26e-04 | 8 | 79 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.59e-04 | 459 | 79 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 5.70e-04 | 41 | 79 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A4 SLC9A4 TMC2 SLC34A2 SLC45A2 OTOP3 SLC1A2 RYR3 SLC45A4 | 8.14e-04 | 627 | 79 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 8.31e-04 | 11 | 79 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 8.31e-04 | 11 | 79 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | channel activity | 1.10e-03 | 525 | 79 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.11e-03 | 526 | 79 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 1.36e-03 | 14 | 79 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.36e-03 | 14 | 79 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 1.57e-03 | 15 | 79 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.02e-03 | 17 | 79 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 4.03e-03 | 24 | 79 | 2 | GO:0017075 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.07e-03 | 81 | 79 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.18e-03 | 165 | 79 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 4.37e-03 | 25 | 79 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.72e-03 | 26 | 79 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.74e-03 | 171 | 79 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.82e-03 | 86 | 79 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 5.47e-03 | 28 | 79 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 6.60e-03 | 188 | 79 | 4 | GO:0015078 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.54e-03 | 33 | 79 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 7.94e-03 | 103 | 79 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 8.92e-03 | 36 | 79 | 2 | GO:0019865 | |
| GeneOntologyBiologicalProcess | intracellular pH elevation | 1.38e-08 | 8 | 79 | 4 | GO:0051454 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A4 SLC35G1 CHRNA6 SLC9A4 SLC26A3 CD4 TMC2 CLCN5 MYO5A SLC26A4 STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 SLC1A2 SLC26A6 RYR3 | 2.89e-08 | 1115 | 79 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A4 SLC35G1 SLC9A4 SLC26A3 CD4 TMC2 CLCN5 MYO5A SLC26A4 STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 SLC26A6 RYR3 | 2.33e-07 | 1017 | 79 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC35A3 SLC26A3 SLC16A9 SLCO2A1 SLC26A4 CFTR SLC35A2 SLC35C2 SERINC5 SLC44A4 SLC1A2 SLC26A6 | 5.79e-07 | 515 | 79 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A4 SLC35G1 CHRNA6 SLC9A4 SLC26A3 CD4 TMC2 CLCN5 MYO5A SLC26A4 STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 SLC1A2 SLC26A6 RYR3 | 7.41e-07 | 1374 | 79 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 5.00e-06 | 65 | 79 | 5 | GO:0072348 | |
| GeneOntologyBiologicalProcess | regulation of pH | 6.72e-06 | 120 | 79 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | oxalate transport | 1.16e-05 | 12 | 79 | 3 | GO:0019532 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 1.16e-05 | 12 | 79 | 3 | GO:0090481 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.33e-05 | 38 | 79 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 1.33e-05 | 38 | 79 | 4 | GO:0070633 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 1.50e-05 | 13 | 79 | 3 | GO:0015780 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 2.69e-05 | 153 | 79 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | sulfate transmembrane transport | 2.92e-05 | 16 | 79 | 3 | GO:1902358 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 3.05e-05 | 94 | 79 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 4.31e-05 | 101 | 79 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | UDP-galactose transmembrane transport | 4.33e-05 | 3 | 79 | 2 | GO:0072334 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A4 SLC35G1 SLC9A4 CD4 TMC2 MYO5A STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 RYR3 | 4.47e-05 | 922 | 79 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A4 SLC35G1 SLC9A4 CD4 TMC2 MYO5A STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 RYR3 | 5.56e-05 | 942 | 79 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 6.66e-05 | 180 | 79 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 7.06e-05 | 112 | 79 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 7.30e-05 | 183 | 79 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A SLC26A4 CFTR STEAP4 SLC45A2 FXYD2 SLC26A6 RYR3 | 7.50e-05 | 705 | 79 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | carbohydrate transport | 7.99e-05 | 186 | 79 | 6 | GO:0008643 | |
| GeneOntologyBiologicalProcess | oligosaccharide transport | 8.65e-05 | 4 | 79 | 2 | GO:0015772 | |
| GeneOntologyBiologicalProcess | sucrose transport | 8.65e-05 | 4 | 79 | 2 | GO:0015770 | |
| GeneOntologyBiologicalProcess | disaccharide transport | 8.65e-05 | 4 | 79 | 2 | GO:0015766 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A SLC26A4 CFTR STEAP4 SLC45A2 FXYD2 SLC26A6 RYR3 | 8.72e-05 | 717 | 79 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A CFTR STEAP4 SLC45A2 FXYD2 SLC26A6 RYR3 | 1.11e-04 | 611 | 79 | 10 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A CFTR STEAP4 SLC45A2 FXYD2 SLC26A6 RYR3 | 1.28e-04 | 622 | 79 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | chloride transport | 1.33e-04 | 128 | 79 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.65e-04 | 134 | 79 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 2.16e-04 | 142 | 79 | 5 | GO:0046683 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A SLC26A4 CFTR PEX2 STEAP4 SLC34A2 SLC45A2 G6PC2 FXYD2 SLC26A6 RYR3 | 2.54e-04 | 1249 | 79 | 14 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of dopamine secretion | 2.97e-04 | 34 | 79 | 3 | GO:0014059 | |
| GeneOntologyBiologicalProcess | reactive gliosis | 3.00e-04 | 7 | 79 | 2 | GO:0150103 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A CFTR STEAP4 SLC34A2 SLC45A2 FXYD2 SLC26A6 RYR3 PINK1 | 3.38e-04 | 981 | 79 | 12 | GO:0019725 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A4 SLC35G1 SLC9A4 CD4 TMC2 MYO5A STIMATE CFTR STEAP4 SLC34A2 FXYD2 RYR3 | 4.02e-04 | 1000 | 79 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A4 SLC35G1 SLC9A4 CD4 TMC2 MYO5A STIMATE CFTR STEAP4 SLC34A2 OTOP3 FXYD2 RYR3 | 4.24e-04 | 1157 | 79 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 4.43e-04 | 166 | 79 | 5 | GO:0014074 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLC35G1 SLC9A4 SLC26A3 MYO5A CFTR STEAP4 SLC34A2 SLC45A2 FXYD2 SLC26A6 RYR3 | 4.46e-04 | 866 | 79 | 11 | GO:0055082 |
| GeneOntologyBiologicalProcess | sperm capacitation | 5.19e-04 | 41 | 79 | 3 | GO:0048240 | |
| GeneOntologyBiologicalProcess | dopamine secretion | 5.19e-04 | 41 | 79 | 3 | GO:0014046 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 6.30e-04 | 273 | 79 | 6 | GO:0034764 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 6.39e-04 | 10 | 79 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | signal release | 8.64e-04 | 653 | 79 | 9 | GO:0023061 | |
| GeneOntologyBiologicalProcess | epithelial fluid transport | 9.32e-04 | 12 | 79 | 2 | GO:0042045 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 9.87e-04 | 410 | 79 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 1.02e-03 | 412 | 79 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.03e-03 | 116 | 79 | 4 | GO:0015844 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, dopaminergic | 1.10e-03 | 13 | 79 | 2 | GO:0032225 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.10e-03 | 53 | 79 | 3 | GO:0071320 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 1.17e-03 | 120 | 79 | 4 | GO:0006835 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.22e-03 | 208 | 79 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | dopamine transport | 1.36e-03 | 57 | 79 | 3 | GO:0015872 | |
| GeneOntologyBiologicalProcess | export from cell | SLC6A4 ILDR2 SLC35G1 CHRNA6 MYO5A CFTR MRGPRX2 EXOC3L1 G6PC2 SLC44A4 FXYD2 PINK1 | 1.40e-03 | 1153 | 79 | 12 | GO:0140352 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC9A4 SLC26A3 PTPRH SLC26A4 CFTR SLC34A2 CLDN25 SLC44A4 MUC4 MTDH WDPCP SLC26A6 | 2.78e-07 | 487 | 79 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | SLC9A4 SLC26A3 CLCN5 PTPRH SLC26A4 CFTR SLC34A2 CLDN25 SLC44A4 MUC4 MTDH WDPCP SLC26A6 | 3.15e-07 | 592 | 79 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RCE1 POMT2 ILDR2 SLC35G1 CD4 DNAJC14 HLA-DQB1 HLA-DQB2 STIMATE GUCY2D CFTR SLC35A2 LPCAT4 ALG3 FLRT2 G6PC2 MTDH RYR3 | 1.16e-06 | 1293 | 79 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RCE1 POMT2 ILDR2 SLC35G1 CD4 DNAJC14 HLA-DQB1 HLA-DQB2 STIMATE GUCY2D CFTR SLC35A2 LPCAT4 ALG3 FLRT2 G6PC2 MTDH RYR3 | 1.24e-06 | 1299 | 79 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RCE1 POMT2 ILDR2 SLC35G1 CD4 DNAJC14 HLA-DQB1 HLA-DQB2 STIMATE GUCY2D CFTR SLC35A2 LPCAT4 ALG3 FLRT2 G6PC2 MTDH RYR3 | 1.68e-06 | 1327 | 79 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | lumenal side of membrane | 3.24e-05 | 48 | 79 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | cell projection membrane | HHIP SLC26A3 PTPRH SLC26A4 GUCY2D SLC34A2 MUC4 SLC1A2 SLC26A6 | 3.56e-05 | 431 | 79 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC6A4 SLC9A4 ATP8B4 CD4 CLCN5 HLA-DQB1 HLA-DQB2 CFTR STEAP4 SLC45A2 GPRC5C GPRC5A DCST1 SLC26A6 GDE1 | 9.82e-05 | 1307 | 79 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SLC6A4 SLC9A4 ATP8B4 CD4 CLCN5 HLA-DQB1 HLA-DQB2 CFTR STEAP4 SLC45A2 GPRC5C GPRC5A DCST1 SLC26A6 GDE1 | 1.14e-04 | 1325 | 79 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 2.29e-04 | 79 | 79 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | brush border membrane | 2.77e-04 | 83 | 79 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.12e-04 | 35 | 79 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | microvillus membrane | 3.98e-04 | 38 | 79 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 5.84e-04 | 101 | 79 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | actin-based cell projection | 6.47e-04 | 278 | 79 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | microvillus | 1.22e-03 | 123 | 79 | 4 | GO:0005902 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.57e-03 | 223 | 79 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.85e-03 | 17 | 79 | 2 | GO:0042613 | |
| GeneOntologyCellularComponent | tight junction | 1.91e-03 | 139 | 79 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 2.34e-03 | 147 | 79 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | brush border | 2.65e-03 | 152 | 79 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | apical junction complex | 3.04e-03 | 158 | 79 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | astrocyte projection | 4.00e-03 | 25 | 79 | 2 | GO:0097449 | |
| GeneOntologyCellularComponent | MHC protein complex | 4.32e-03 | 26 | 79 | 2 | GO:0042611 | |
| Domain | S04_transporter_CS | 2.42e-06 | 7 | 78 | 3 | IPR018045 | |
| Domain | SLC26A | 8.23e-06 | 10 | 78 | 3 | PS01130 | |
| Domain | STAS | 1.13e-05 | 11 | 78 | 3 | PS50801 | |
| Domain | STAS_dom | 1.13e-05 | 11 | 78 | 3 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 1.13e-05 | 11 | 78 | 3 | IPR011547 | |
| Domain | STAS | 1.13e-05 | 11 | 78 | 3 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.13e-05 | 11 | 78 | 3 | IPR001902 | |
| Domain | - | 1.13e-05 | 11 | 78 | 3 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.13e-05 | 11 | 78 | 3 | PF00916 | |
| Domain | GPCR_3 | 8.83e-05 | 21 | 78 | 3 | IPR000337 | |
| Domain | 7tm_3 | 1.02e-04 | 22 | 78 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.02e-04 | 22 | 78 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.02e-04 | 22 | 78 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.02e-04 | 22 | 78 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.02e-04 | 22 | 78 | 3 | PS50259 | |
| Domain | GPCR_3_C | 1.02e-04 | 22 | 78 | 3 | IPR017978 | |
| Domain | Nuc_sug_transpt | 1.71e-04 | 5 | 78 | 2 | IPR007271 | |
| Domain | Nuc_sug_transp | 1.71e-04 | 5 | 78 | 2 | PF04142 | |
| Domain | MHC_II_b_N | 4.74e-04 | 8 | 78 | 2 | PD000328 | |
| Domain | MHC_II_beta | 6.08e-04 | 9 | 78 | 2 | PF00969 | |
| Domain | MHC_II_b_N | 6.08e-04 | 9 | 78 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 6.08e-04 | 9 | 78 | 2 | SM00921 | |
| Domain | MIR | 7.58e-04 | 10 | 78 | 2 | PS50919 | |
| Domain | MIR | 7.58e-04 | 10 | 78 | 2 | PF02815 | |
| Domain | MIR | 7.58e-04 | 10 | 78 | 2 | SM00472 | |
| Domain | MIR_motif | 7.58e-04 | 10 | 78 | 2 | IPR016093 | |
| Domain | MHC_II_a/b_N | 1.52e-03 | 14 | 78 | 2 | IPR014745 | |
| Domain | - | 1.52e-03 | 14 | 78 | 2 | 3.10.320.10 | |
| Domain | Neurexin-like | 1.52e-03 | 14 | 78 | 2 | IPR003585 | |
| Domain | 4.1m | 1.52e-03 | 14 | 78 | 2 | SM00294 | |
| Domain | MFS_dom | 2.40e-03 | 134 | 78 | 4 | IPR020846 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A4 SLC35A3 SLC26A3 ATP8B4 CLCN5 SLCO2A1 SLC26A4 CFTR SLC35A2 STEAP4 SLC34A2 SLC44A4 FXYD2 SLC1A2 SLC26A6 RYR3 | 2.52e-08 | 681 | 62 | 16 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A4 SLC35A3 SLC26A3 ATP8B4 CLCN5 SLCO2A1 SLC26A4 CFTR SLC35A2 STEAP4 SLC34A2 SLC44A4 FXYD2 SLC1A2 SLC26A6 RYR3 | 7.42e-08 | 736 | 62 | 16 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A4 SLC35A3 SLC26A3 SLCO2A1 SLC26A4 SLC35A2 SLC34A2 SLC44A4 SLC1A2 SLC26A6 | 7.76e-08 | 238 | 62 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A4 SLC35A3 SLC26A3 SLCO2A1 SLC26A4 SLC35A2 SLC34A2 SLC44A4 SLC1A2 SLC26A6 | 1.18e-07 | 249 | 62 | 10 | M5988 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 4.61e-06 | 99 | 62 | 6 | M27474 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 6.68e-06 | 9 | 62 | 3 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 6.68e-06 | 9 | 62 | 3 | MM15084 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 7.63e-06 | 108 | 62 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 8.05e-06 | 109 | 62 | 6 | MM15074 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.20e-05 | 177 | 62 | 7 | M27476 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.55e-05 | 15 | 62 | 3 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.55e-05 | 15 | 62 | 3 | MM15845 | |
| Pathway | REACTOME_PD_1_SIGNALING | 2.45e-04 | 28 | 62 | 3 | M18810 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 3.94e-04 | 7 | 62 | 2 | M27501 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 6.61e-04 | 39 | 62 | 3 | M16523 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 6.72e-04 | 9 | 62 | 2 | M27688 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 6.72e-04 | 9 | 62 | 2 | MM15421 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 7.67e-04 | 41 | 62 | 3 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 8.82e-04 | 43 | 62 | 3 | M881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.67e-03 | 14 | 62 | 2 | M47414 | |
| Pubmed | Deletion of Slc26a6 alters the stoichiometry of apical Cl-/HCO-3 exchange in mouse pancreatic duct. | 1.17e-08 | 3 | 80 | 3 | 22895259 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 21068358 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 20969732 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 20164375 | ||
| Pubmed | Role of down-regulated in adenoma anion exchanger in HCO3- secretion across murine duodenum. | 4.68e-08 | 4 | 80 | 3 | 19121635 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 21976599 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 18930060 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 11087667 | ||
| Pubmed | Normal lung development in RAIG1-deficient mice despite unique lung epithelium-specific expression. | 6.51e-07 | 8 | 80 | 3 | 15677768 | |
| Pubmed | Physiological roles and regulation of mammalian sulfate transporters. | 9.75e-07 | 9 | 80 | 3 | 11581495 | |
| Pubmed | N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. | 1.39e-06 | 10 | 80 | 3 | 24647542 | |
| Pubmed | 4.19e-06 | 14 | 80 | 3 | 28851741 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31201468 | ||
| Pubmed | Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice. | 5.23e-06 | 2 | 80 | 2 | 14688093 | |
| Pubmed | Requirements for T cell-polarized tubulation of class II+ compartments in dendritic cells. | 5.23e-06 | 2 | 80 | 2 | 14634076 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 28526688 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11739519 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20381161 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 29079751 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 38829391 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11694883 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30118583 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23583405 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11692102 | ||
| Pubmed | Involvement of Cl(-)/HCO3(-) exchanger SLC26A3 and SLC26A6 in preimplantation embryo cleavage. | 5.23e-06 | 2 | 80 | 2 | 27346053 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16901991 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 27004488 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 27615377 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 36622146 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 7737291 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21914796 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11777987 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 18565999 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20733203 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30742493 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30659943 | ||
| Pubmed | Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. | 5.23e-06 | 2 | 80 | 2 | 21852380 | |
| Pubmed | Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6. | 5.23e-06 | 2 | 80 | 2 | 16606687 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23660504 | ||
| Pubmed | Cloning and characterization of a human orphan family C G-protein coupled receptor GPRC5D. | 5.23e-06 | 2 | 80 | 2 | 11311935 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16799633 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15944260 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 27134178 | ||
| Pubmed | Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. | 5.23e-06 | 2 | 80 | 2 | 15927426 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 22138498 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11459928 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 32541384 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17076705 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17053783 | ||
| Pubmed | Cockroach allergen-induced eosinophilic airway inflammation in HLA-DQ/human CD4(+) transgenic mice. | 5.23e-06 | 2 | 80 | 2 | 11591792 | |
| Pubmed | Alkalosis-induced hypoventilation in cystic fibrosis: The importance of efficient renal adaptation. | 5.23e-06 | 2 | 80 | 2 | 35173044 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26394631 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23089177 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 6.42e-06 | 16 | 80 | 3 | 2846691 | |
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 6.42e-06 | 16 | 80 | 3 | 2543930 | |
| Pubmed | 6.42e-06 | 16 | 80 | 3 | 1978941 | ||
| Pubmed | 7.79e-06 | 17 | 80 | 3 | 15194762 | ||
| Pubmed | 7.79e-06 | 17 | 80 | 3 | 24904546 | ||
| Pubmed | Nef performance in macrophages: the master orchestrator of viral persistence and spread. | 1.30e-05 | 20 | 80 | 3 | 22103834 | |
| Pubmed | 1.30e-05 | 20 | 80 | 3 | 7541827 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 34858415 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 10945465 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 31069134 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 11535811 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 10477611 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 20601923 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 32561639 | ||
| Pubmed | A mathematical model of ENaC and Slc26a6 regulation by CFTR in salivary gland ducts. | 1.57e-05 | 3 | 80 | 2 | 38349781 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 34321274 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 9885917 | ||
| Pubmed | Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. | 1.57e-05 | 3 | 80 | 2 | 19767568 | |
| Pubmed | The G protein-coupled receptor GPRC5B contributes to neurogenesis in the developing mouse neocortex. | 1.57e-05 | 3 | 80 | 2 | 24089469 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 9858518 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 35464453 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 28941661 | ||
| Pubmed | The HSP70 co-chaperone DNAJC14 targets misfolded pendrin for unconventional protein secretion. | 1.57e-05 | 3 | 80 | 2 | 27109633 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 14769854 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 37055914 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 10783259 | ||
| Pubmed | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy. | 1.57e-05 | 3 | 80 | 2 | 35140112 | |
| Pubmed | Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. | 1.57e-05 | 3 | 80 | 2 | 11687799 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17170027 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 12421937 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 15294964 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 16039581 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 22403638 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 25164149 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 27109987 | ||
| Pubmed | An insight into the orphan nucleotide sugar transporter SLC35A4. | 1.57e-05 | 3 | 80 | 2 | 28167211 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 16421216 | ||
| Pubmed | 2.01e-05 | 23 | 80 | 3 | 19770068 | ||
| Pubmed | Editorial. Nef: a notorious enigmatic factor in HIV biology. | 2.29e-05 | 24 | 80 | 3 | 22175768 | |
| Pubmed | 2.60e-05 | 25 | 80 | 3 | 16091223 | ||
| Pubmed | TNFα and IL-17 alkalinize airway surface liquid through CFTR and pendrin. | 3.13e-05 | 4 | 80 | 2 | 32432926 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 17307945 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 3036828 | ||
| Pubmed | Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. | 3.13e-05 | 4 | 80 | 2 | 28371798 | |
| Pubmed | Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice. | 3.13e-05 | 4 | 80 | 2 | 17657247 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 20381429 | ||
| Pubmed | Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy. | 3.13e-05 | 4 | 80 | 2 | 36544781 | |
| Cytoband | Xp11.23-p11.22 | 6.26e-05 | 7 | 80 | 2 | Xp11.23-p11.22 | |
| Cytoband | 2q12.1 | 5.03e-04 | 19 | 80 | 2 | 2q12.1 | |
| Cytoband | 7q31 | 1.02e-03 | 27 | 80 | 2 | 7q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 3.43e-03 | 353 | 80 | 4 | chr12p13 | |
| GeneFamily | Solute carriers | SLC6A4 SLC35G1 SLC9A4 SLC35A3 SLC26A3 SLC16A9 SLCO2A1 SLC26A4 SLC35A2 SLC35C2 SLC34A2 SLC45A2 SLC44A4 SLC1A2 SLC26A6 SLC45A4 | 2.72e-14 | 395 | 55 | 16 | 752 |
| GeneFamily | G protein-coupled receptors, Class C orphans | 9.24e-07 | 7 | 55 | 3 | 285 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 3.23e-04 | 9 | 55 | 2 | 430 | |
| GeneFamily | C1-set domain containing | 7.24e-03 | 42 | 55 | 2 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 7.92e-03 | 44 | 55 | 2 | 588 | |
| Coexpression | BENPORATH_EED_TARGETS | ILDR2 HHIP CLCN5 SLCO2A1 SLC26A4 GUCY2D CFTR STEAP4 FLRT2 OTOP3 SLC1A2 SDC2 RYR3 | 1.58e-05 | 1059 | 79 | 13 | M7617 |
| Coexpression | BENPORATH_PRC2_TARGETS | ILDR2 HHIP CLCN5 SLCO2A1 SLC26A4 GUCY2D FLRT2 OTOP3 SLC1A2 RYR3 | 2.54e-05 | 650 | 79 | 10 | M8448 |
| Coexpression | GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN | 3.03e-05 | 198 | 79 | 6 | M3530 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 3.20e-05 | 200 | 79 | 6 | M7905 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ILDR2 HHIP CLCN5 SLCO2A1 SLC26A4 GUCY2D CFTR FLRT2 OTOP3 SLC1A2 SDC2 RYR3 | 6.02e-05 | 1035 | 79 | 12 | M9898 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | SLC6A4 LYVE1 HHIP MANSC1 SLCO2A1 SLC26A4 EXOC3L1 FLRT2 PRSS23 TSPAN5 | 2.27e-06 | 428 | 74 | 10 | JC_hmvEC_1000_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 1.37e-05 | 415 | 74 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| ToppCell | distal-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.29e-09 | 199 | 78 | 8 | c0275b5011c2bb08e873955afe2e213ec8070d0e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.66e-08 | 185 | 78 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 5.44e-08 | 196 | 78 | 7 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-08 | 197 | 78 | 7 | ec08a971e8dd9ad69359896c60ad77ff8af08fd0 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.83e-08 | 198 | 78 | 7 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-08 | 199 | 78 | 7 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 6.03e-08 | 199 | 78 | 7 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | distal-Epithelial-Mucous-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-08 | 199 | 78 | 7 | 0af89ef40807fc4ad79ab82a2186ab6e866c6931 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.25e-08 | 200 | 78 | 7 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.25e-08 | 200 | 78 | 7 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.25e-08 | 200 | 78 | 7 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.25e-08 | 200 | 78 | 7 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 6.25e-08 | 200 | 78 | 7 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.53e-07 | 187 | 78 | 6 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.01e-06 | 189 | 78 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-06 | 193 | 78 | 6 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-06 | 193 | 78 | 6 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 193 | 78 | 6 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 105 | 78 | 5 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 194 | 78 | 6 | 855d6acfcf323868ba98b213f06186ad4793d4ed | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 194 | 78 | 6 | dc531cf9089f2c956621d70d49a2b8219b4b45c1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 194 | 78 | 6 | 29a7770bdbea6081a9ed64a997cd92a1cbf4af58 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 194 | 78 | 6 | ca051088f880154ae2fd3f0ab3cef5a8dba8c371 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 195 | 78 | 6 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | normal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.22e-06 | 195 | 78 | 6 | 7c90d887afde5c4d63352b5171be9987e2dfca58 | |
| ToppCell | ASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.22e-06 | 195 | 78 | 6 | 1cdaab17866a1e5170e0f6bfcc69134425fdd8df | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-06 | 196 | 78 | 6 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.25e-06 | 196 | 78 | 6 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.29e-06 | 197 | 78 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.29e-06 | 197 | 78 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 3'-Adult|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-06 | 198 | 78 | 6 | 302adb42089ff22fffc4f01af572ca2e151f7ce7 | |
| ToppCell | medial-2-Epithelial-Club|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-06 | 198 | 78 | 6 | 7f59d949190c10af13cbd13f81a795483deb9d14 | |
| ToppCell | medial-Epithelial-Club|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-06 | 198 | 78 | 6 | a861cf5bb1950ed5f0363b8a834a1c246e151389 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-06 | 198 | 78 | 6 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | medial-Epithelial-Club-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-06 | 198 | 78 | 6 | da7881351a71cde926325ab3e22d772f64cfab80 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-06 | 198 | 78 | 6 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | medial-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 78 | 6 | 4737250b7ffa7cc19eb6b057d35d78f13b1afe66 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-06 | 199 | 78 | 6 | b44d74895846e2ac144438b73e0ca91e3949c16c | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.37e-06 | 199 | 78 | 6 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-06 | 199 | 78 | 6 | 4b374a5de82b4614d3d8a00202ea6cb8f1fd8104 | |
| ToppCell | medial-Epithelial-Mucous|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 78 | 6 | 4385963ab25b5378e7964b984028c25b27e5794e | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.37e-06 | 199 | 78 | 6 | 9e8231c9007d8d963805a4c99e0905538ceb9b60 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.37e-06 | 199 | 78 | 6 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | medial-Epithelial-Mucous-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 78 | 6 | 53198bcf5f2f012a3ed1600d95c0923d6976a099 | |
| ToppCell | distal-Epithelial-Mucous|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 78 | 6 | a7fe7b792d696f369ad0310a772160a1729ef223 | |
| ToppCell | proximal|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.41e-06 | 200 | 78 | 6 | 33f05ed458c889bf241580f513ce66797007248c | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.41e-06 | 200 | 78 | 6 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-06 | 200 | 78 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.41e-06 | 200 | 78 | 6 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 78 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 78 | 6 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-06 | 200 | 78 | 6 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 78 | 6 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 78 | 6 | 8f811ddd84c037a250d124496b0fbb2e4717011c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-06 | 200 | 78 | 6 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| ToppCell | distal-3-Epithelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.41e-06 | 200 | 78 | 6 | 698c09d383b652178e4e150151139031b6e891bc | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-06 | 111 | 78 | 5 | a1b7940c6fa0e5a58aa4798b604469d79f33fa44 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-06 | 111 | 78 | 5 | d1ec8e8e9adb11511b4ef363cc6f99286e2cc842 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-06 | 111 | 78 | 5 | 567e5ac2c78d45db207067f0f152bb24ed048c50 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-06 | 111 | 78 | 5 | fd7aa25e83a0d762969e3966a658652da40c490e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-06 | 111 | 78 | 5 | d48561078c387ac856c1c30e3d7a3e75ebde942e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-06 | 155 | 78 | 5 | 96c48d835725eac1bc7926f4cddecb67c29b7d7c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.87e-06 | 159 | 78 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.71e-06 | 162 | 78 | 5 | 10f7de4fb40ea9aee89bde3a280a82f6ccba2aeb | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 164 | 78 | 5 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 164 | 78 | 5 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 165 | 78 | 5 | ce79d217df88035457cd58f679e72dd98722ae22 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 166 | 78 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 166 | 78 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 166 | 78 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 170 | 78 | 5 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 171 | 78 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 171 | 78 | 5 | e7dbee63cc39230aa12e7868ec78a129160c0d22 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 171 | 78 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 171 | 78 | 5 | b0d616699e2110ffd6cf1868ed1f1a29f824e1fc | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.37e-05 | 174 | 78 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 175 | 78 | 5 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-05 | 177 | 78 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-05 | 177 | 78 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 178 | 78 | 5 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 179 | 78 | 5 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 179 | 78 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 179 | 78 | 5 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.57e-05 | 179 | 78 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 180 | 78 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 180 | 78 | 5 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 181 | 78 | 5 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-05 | 181 | 78 | 5 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 181 | 78 | 5 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.66e-05 | 181 | 78 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.75e-05 | 183 | 78 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.80e-05 | 184 | 78 | 5 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 185 | 78 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 185 | 78 | 5 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 185 | 78 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.89e-05 | 186 | 78 | 5 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.89e-05 | 186 | 78 | 5 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.89e-05 | 186 | 78 | 5 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| Drug | niflumic acid | 2.43e-07 | 125 | 78 | 7 | CID000004488 | |
| Drug | furosemide | 4.26e-06 | 272 | 78 | 8 | CID000003440 | |
| Drug | 3-iodothyronamine | 4.84e-06 | 33 | 78 | 4 | ctd:C487948 | |
| Drug | bumetanide | 7.56e-06 | 209 | 78 | 7 | CID000002471 | |
| Drug | oxalate | 1.73e-05 | 158 | 78 | 6 | CID000000971 | |
| Disease | primary sclerosing cholangitis (is_implicated_in) | 6.55e-06 | 2 | 76 | 2 | DOID:0060643 (is_implicated_in) | |
| Disease | Autoimmune Hepatitis | 2.11e-05 | 21 | 76 | 3 | EFO_0005676 | |
| Disease | frailty measurement | 2.80e-05 | 23 | 76 | 3 | EFO_0009885 | |
| Disease | perceived unattractiveness to mosquitos measurement | 3.66e-05 | 72 | 76 | 4 | EFO_0008380 | |
| Disease | type 1 diabetes mellitus, latent autoimmune diabetes in adults | 3.92e-05 | 4 | 76 | 2 | EFO_0009706, MONDO_0005147 | |
| Disease | HPV seropositivity | 6.51e-05 | 5 | 76 | 2 | EFO_0004510 | |
| Disease | level of coiled-coil domain-containing protein 134 in blood serum | 6.51e-05 | 5 | 76 | 2 | OBA_2044258 | |
| Disease | typhoid fever (is_implicated_in) | 6.51e-05 | 5 | 76 | 2 | DOID:13258 (is_implicated_in) | |
| Disease | Varicella zoster virus seropositivity | 6.51e-05 | 5 | 76 | 2 | EFO_0009340 | |
| Disease | narcolepsy-cataplexy syndrome, age at onset | 6.51e-05 | 5 | 76 | 2 | EFO_0004847, MONDO_0016158 | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 7.01e-05 | 31 | 76 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | chronic hepatitis C virus infection | 8.47e-05 | 33 | 76 | 3 | EFO_0004220 | |
| Disease | allergic bronchopulmonary aspergillosis (is_implicated_in) | 9.75e-05 | 6 | 76 | 2 | DOID:13166 (is_implicated_in) | |
| Disease | antibody measurement, Epstein-Barr virus infection | 9.75e-05 | 6 | 76 | 2 | EFO_0000769, EFO_0004556 | |
| Disease | pemphigus | 9.75e-05 | 6 | 76 | 2 | EFO_1000749 | |
| Disease | pneumocystosis (biomarker_via_orthology) | 9.75e-05 | 6 | 76 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | Goiter | 1.36e-04 | 7 | 76 | 2 | C0018021 | |
| Disease | Anti-Helicobacter pylori IgG measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0009352 | |
| Disease | antinuclear antibody measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0005949 | |
| Disease | myositis | 1.40e-04 | 39 | 76 | 3 | EFO_0000783 | |
| Disease | hepatocellular carcinoma | 1.63e-04 | 41 | 76 | 3 | EFO_0000182 | |
| Disease | human papilloma virus infection, oral cavity cancer | 1.75e-04 | 42 | 76 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | IgG index | 1.81e-04 | 8 | 76 | 2 | EFO_0006929 | |
| Disease | soluble CD163 measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0020072 | |
| Disease | gdnf family receptor alpha-1 measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0020400 | |
| Disease | PAX-interacting protein 1 measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0801868 | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 2.33e-04 | 9 | 76 | 2 | EFO_0803299 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 2.33e-04 | 9 | 76 | 2 | EFO_0007790 | |
| Disease | inclusion body myositis | 2.33e-04 | 9 | 76 | 2 | EFO_0007323 | |
| Disease | head and neck malignant neoplasia | 2.33e-04 | 9 | 76 | 2 | EFO_0006859 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 2.33e-04 | 9 | 76 | 2 | EFO_0801686 | |
| Disease | seropositivity measurement | 2.33e-04 | 9 | 76 | 2 | EFO_0007034 | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 2.33e-04 | 9 | 76 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | cannabis dependence measurement | 2.61e-04 | 48 | 76 | 3 | EFO_0008457 | |
| Disease | cutaneous melanoma | 2.75e-04 | 121 | 76 | 4 | EFO_0000389 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 2.91e-04 | 10 | 76 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | secreted and transmembrane protein 1 measurement | 2.91e-04 | 10 | 76 | 2 | EFO_0021852 | |
| Disease | peptidoglycan recognition protein 1 measurement | 2.91e-04 | 10 | 76 | 2 | EFO_0020624 | |
| Disease | CCL19 measurement | 2.91e-04 | 10 | 76 | 2 | EFO_0009415 | |
| Disease | head and neck squamous cell carcinoma | 3.55e-04 | 11 | 76 | 2 | EFO_0000181 | |
| Disease | chronic bronchitis | 3.55e-04 | 11 | 76 | 2 | EFO_0006505 | |
| Disease | apolipoprotein M measurement | 3.55e-04 | 11 | 76 | 2 | EFO_0021945 | |
| Disease | uveitis (implicated_via_orthology) | 3.55e-04 | 11 | 76 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 3.55e-04 | 11 | 76 | 2 | EFO_0020224 | |
| Disease | rac GTPase-activating protein 1 measurement | 4.25e-04 | 12 | 76 | 2 | EFO_0801985 | |
| Disease | cataract | 4.91e-04 | 141 | 76 | 4 | MONDO_0005129 | |
| Disease | Genetic chronic primary adrenal insufficiency | 5.01e-04 | 13 | 76 | 2 | Orphanet_101960 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 5.01e-04 | 13 | 76 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 5.83e-04 | 63 | 76 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | C-C motif chemokine 19 measurement | 5.84e-04 | 14 | 76 | 2 | EFO_0008047 | |
| Disease | oral cavity cancer | 5.84e-04 | 14 | 76 | 2 | EFO_0005570 | |
| Disease | oligoclonal band measurement, multiple sclerosis | 5.84e-04 | 14 | 76 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | liver neoplasm | 6.73e-04 | 15 | 76 | 2 | EFO_1001513 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 6.73e-04 | 15 | 76 | 2 | EFO_0009935 | |
| Disease | Churg-Strauss syndrome | 6.73e-04 | 15 | 76 | 2 | EFO_0007208 | |
| Disease | worry measurement | 6.84e-04 | 154 | 76 | 4 | EFO_0009589 | |
| Disease | pemphigus vulgaris | 7.67e-04 | 16 | 76 | 2 | EFO_0004719 | |
| Disease | gastroparesis | 7.67e-04 | 16 | 76 | 2 | EFO_1000948 | |
| Disease | metabolite measurement, diet measurement | 8.27e-04 | 71 | 76 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | Antihistamine use measurement | 8.68e-04 | 17 | 76 | 2 | EFO_0009943 | |
| Disease | high altitude adaptation | 8.68e-04 | 17 | 76 | 2 | EFO_0009105 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 8.68e-04 | 17 | 76 | 2 | EFO_0010559, GO_0035456 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 8.68e-04 | 17 | 76 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | skin neoplasm | 9.33e-04 | 74 | 76 | 3 | EFO_0004198 | |
| Disease | serum IgG measurement | 9.75e-04 | 18 | 76 | 2 | EFO_0004565 | |
| Disease | tropical spastic paraparesis | 9.75e-04 | 18 | 76 | 2 | EFO_0007527 | |
| Disease | nevus count | 9.75e-04 | 18 | 76 | 2 | EFO_0004632 | |
| Disease | angiopoietin-1 receptor measurement | 1.09e-03 | 19 | 76 | 2 | EFO_0010600 | |
| Disease | hepatitis B virus infection | 1.09e-03 | 19 | 76 | 2 | EFO_0004197 | |
| Disease | susceptibility to scarlet fever measurement | 1.13e-03 | 79 | 76 | 3 | EFO_0008409 | |
| Disease | neoplasm of mature B-cells | 1.21e-03 | 20 | 76 | 2 | EFO_0000096 | |
| Disease | polymyositis | 1.21e-03 | 20 | 76 | 2 | EFO_0003063 | |
| Disease | Nerve Degeneration | 1.30e-03 | 83 | 76 | 3 | C0027746 | |
| Disease | C-peptide measurement | 1.46e-03 | 22 | 76 | 2 | EFO_0005187 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.46e-03 | 22 | 76 | 2 | EFO_0021881 | |
| Disease | Henoch-Schoenlein purpura | 1.46e-03 | 22 | 76 | 2 | EFO_1000965 | |
| Disease | feeling nervous measurement | 1.49e-03 | 87 | 76 | 3 | EFO_0009597 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 1.60e-03 | 328 | 76 | 5 | EFO_0008377, EFO_0008378 | |
| Disease | remission, hepatitis C virus infection | 1.60e-03 | 23 | 76 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | gestational diabetes | 1.60e-03 | 23 | 76 | 2 | EFO_0004593 | |
| Disease | lymphoma | 1.74e-03 | 24 | 76 | 2 | EFO_0000574 | |
| Disease | chronic hepatitis B virus infection | 1.74e-03 | 24 | 76 | 2 | EFO_0004239 | |
| Disease | drug-induced liver injury | 1.74e-03 | 24 | 76 | 2 | EFO_0004228 | |
| Disease | atopic asthma | 1.76e-03 | 199 | 76 | 4 | EFO_0010638 | |
| Disease | peak expiratory flow | 1.81e-03 | 498 | 76 | 6 | EFO_0009718 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 2.04e-03 | 26 | 76 | 2 | EFO_0010366 | |
| Disease | L lactate dehydrogenase measurement | 2.04e-03 | 26 | 76 | 2 | EFO_0004808 | |
| Disease | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | 2.37e-03 | 28 | 76 | 2 | EFO_0000183, EFO_0001378, EFO_0005952 | |
| Disease | Pigmented Basal Cell Carcinoma | 2.37e-03 | 28 | 76 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 2.54e-03 | 29 | 76 | 2 | C4721806 | |
| Disease | pulmonary tuberculosis | 2.54e-03 | 29 | 76 | 2 | EFO_1000049 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGLELPVFQGLDLLF | 181 | Q86VI1 | |
| LGFLVAFLLLGLVGM | 1286 | P78357 | |
| GLGFLIVLALFQAGL | 226 | P13569 | |
| PGLLFLLLTQFGFRG | 216 | Q92685 | |
| GAIFLAGLVLNGLAL | 61 | Q99678 | |
| AAGIFLALGGLLLIF | 171 | C9JDP6 | |
| FGFLICLGIILAIGN | 281 | Q8TF62 | |
| FLLAGLIGGAVIFVL | 541 | O43155 | |
| FLLGVLGIFGLTFAF | 71 | Q8NFJ5 | |
| GVILLLLIGQLEGFF | 241 | Q9HBI0 | |
| LFFLHFLGGGEGLLL | 101 | A0A096LPK9 | |
| FSGFCVLLGGFILLL | 466 | Q7RTY1 | |
| GIFFGALGGLLLLGV | 5371 | Q99102 | |
| SGLLALNVVFLGGAF | 91 | Q7RTS5 | |
| GVGLFTRFLKLLGAL | 316 | Q6Y2X3 | |
| GVAGLVLLFLGILLF | 451 | P59901 | |
| LVLALLFFGAAAGLG | 241 | Q9Y5Y7 | |
| NGVLGLSRLLFFLLG | 91 | Q643R3 | |
| LEPGLVFLGFLLVVG | 461 | Q02846 | |
| LVLAGGFFLLGFLFG | 26 | Q04609 | |
| GFVLGLIFLGLGLII | 236 | P05538 | |
| AGYALGVGLFLLLLQ | 286 | Q9Y256 | |
| FLAFGLGLGLIEEKQ | 101 | Q9BXM7 | |
| LFFLHFLGGGEGLLL | 101 | Q8NGD1 | |
| LFFLHFLGGGEGLLL | 101 | Q8N0Y3 | |
| FVIGLLKLGGLINFL | 141 | P28328 | |
| LIGSLLFGVLFLVIG | 386 | Q9H8J5 | |
| LFGVLFLVIGLVLLG | 391 | Q9H8J5 | |
| LLGTQVFFLLGTLGL | 86 | Q9NQ84 | |
| LGVLLFKLGVFTRGQ | 471 | O95876 | |
| GGFVLGLIFLGLGLI | 236 | P01920 | |
| VFGTAGLFLQPLLGN | 476 | Q15825 | |
| DQGGLLGPFSFLLLV | 6 | Q9NZC3 | |
| LLFLGLFGVLGAATI | 16 | Q8WZ79 | |
| LGLFGLAFAFIIELN | 71 | Q9NZD1 | |
| AGGLLAIGLFQLLVN | 56 | Q5T197 | |
| NVLGLIGFFIAFGIA | 241 | P43004 | |
| LFELVPFILLGIFGG | 386 | P51795 | |
| AGLLLFIGLGIFFCV | 406 | P01730 | |
| FAGLVRNLGVLFGLG | 256 | Q9NQR9 | |
| LFLLRALGFLIGLVG | 11 | Q6GMR7 | |
| TGALGLLLLFLLGYG | 56 | Q86UE4 | |
| VRNGGLIFAGLAFIV | 26 | P54710 | |
| DLLLFFGKLLVVGGV | 596 | Q53GD3 | |
| GLLGFIGPDNLVFIV | 791 | Q14689 | |
| AGGVIGFLFAIFLIL | 151 | P34741 | |
| LLFGLGTGFIGLFPN | 406 | Q9UMX9 | |
| VLFLGAIGRIDFLQG | 536 | Q8NC60 | |
| LAGALGVKFVGLFII | 236 | Q9UKY4 | |
| FLLLAALLGLPGNGF | 26 | Q9NPC1 | |
| VGLFQVGLGLIHFGF | 191 | Q9BXS9 | |
| GLLFLLFFLLCAVGQ | 6 | O95084 | |
| GKVLFLGLLAFGALA | 56 | Q9Y6C5 | |
| FGLGDVNLLQNLLFG | 186 | Q6AI14 | |
| VLFLGGGLLLRAQGL | 51 | A0A2R8YCJ5 | |
| SGIIQLAFGILRIGF | 186 | P40879 | |
| LILFIALVGLVGNGF | 36 | Q96LB1 | |
| QLLFGPDGFLYIILG | 356 | Q96QV1 | |
| LQLGLFGTALGLVGL | 236 | P78381 | |
| QGIGRLILLLGFLYF | 96 | O95436 | |
| LFGVALFLNGSAIGL | 131 | Q5BKX6 | |
| IGIGGLFLAAGAFIL | 101 | Q92959 | |
| VGIIQLIFGGLQIGF | 196 | O43511 | |
| GLVLLGVFLFFVLVG | 191 | Q71H61 | |
| LFVGLFQLLFTILGG | 4191 | Q15413 | |
| GGFLFIGIQLLLLVE | 161 | Q86VE9 | |
| RVLGSLFLGGILAFG | 241 | Q9NQQ7 | |
| LGILGFFLFVLLGIT | 351 | Q687X5 | |
| LIAAGVFLVIFGLLG | 121 | Q9BZD6 | |
| FGIFLQGLLGVVAFS | 36 | Q86TL2 | |
| VAGIFIGIALLQIFG | 236 | P62079 | |
| LGLLSLGFENFIRVG | 1706 | Q86YA3 | |
| LFLIFIGLFGLGGQI | 286 | Q2M3R5 | |
| IGLFGLGGQIFITKA | 291 | Q2M3R5 | |
| IRNIQLGFFGSIFGL | 206 | Q9Y2D2 | |
| FLSAIFLGGLFLVLI | 86 | A2RU14 | |
| LLLAGLSLRGQGNFF | 301 | O94901 | |
| GVNLVLFGLIFGLVI | 261 | Q8TDI7 | |
| AQIFFSLGPGFGVLL | 331 | P31645 | |
| AIFFGALFGALGVLL | 6 | Q6ZP80 | |
| ALFGALGVLLFLVAF | 11 | Q6ZP80 | |
| AGAFVGILLFLILVG | 756 | Q9HD43 | |
| FRILAGILHLGNVGF | 326 | Q9Y4I1 |